EnWave Signs Technology Evaluation and License Option Agreement with Major Australasian Dairy Processor
(firmenpresse) - EnWave Signs Technology Evaluation and License Option Agreement with Major Australasian Dairy Processor
Vancouver, B.C., May 9, 2017
EnWave Corporation (TSX-V:ENW | FSE:E4U) (EnWave, or the "Company" - http://www.commodity-tv.net/c/search_adv/?v=297291) announces today that it has signed a Technology Evaluation and License Option Agreement (the TELOA) with a major Australasian dairy processor (the Research Partner) to explore the potential for dried dairy applications processed by the Companys patented Radiant Energy Vacuum (REV) dehydration technology. The Research Partner will have the exclusive option to license the use of REV technology for the production of dairy products within an agreed Australasian territory for a period of six months.
EnWave has entered into TELOA agreements with several leading dairy processors in the United States, Canada, Mexico, Australia and Europe. Thus far, the Company has signed nine commercial royalty-bearing licenses with dairy processing companies located in Canada, the United States, Portugal, Spain, Turkey, Greece, Costa Rica, Australia and Chile.
About EnWave
EnWave Corporation, a Vancouver-based advanced technology company, has developed Radiant Energy Vacuum (REV) - an innovative, proprietary method for the precise dehydration of organic materials. REV technologys commercial viability has been demonstrated and is growing rapidly across several market verticals in the food and pharmaceutical sectors. EnWaves strategy is to sign royalty-bearing commercial licenses with industry leaders in multiple verticals for the use of REV technology. The company has signed twenty royalty-bearing licenses to date, opening up eight distinct market sectors for commercialization of new and innovative products. In addition to these licenses, EnWave has formed a Limited Liability Partnership, NutraDried LLP, to develop, manufacture, market and sell all-natural cheese snack products in the United States under the Moon Cheese® brand.
EnWave has introduced REV as the new dehydration standard in the food and biological material sectors: faster and cheaper than freeze drying, with better end product quality than air drying or spray drying. EnWave currently has three commercial REV platforms:
1.-nutraREV® which is used in the food industry to dry food products quickly and at low-cost, while maintaining high levels of nutrition, taste, texture and colour;
2.-powderREV® which is used for the bulk dehydration of food cultures, probiotics and fine biochemicals such as enzymes below the freezing point, and
3.-quantaREV® which is used for continuous, high-volume low-temperature drying.
An additional platform, freezeREV®, is being developed as a new method to stabilize and dehydrate biopharmaceuticals such as vaccines and antibodies. More information about EnWave is available at www.enwave.net.
EnWave Corporation
Dr. Tim Durance
President & CEO
For further information:
John Budreski, Executive Chairman at +1 (416) 930-0914
E-mail: jbudreski(at)enwave.net
Brent Charleton, Senior Vice President, Business Development at +1 (778) 378-9616
E-mail: bcharleton(at)enwave.net
Jeremy Hellman, Senior Associate, The Equity Group at +1 (212) 836-9626
E-mail: jhellman(at)equityny.com
Safe Harbour for Forward-Looking Information Statements: This press release may contain forward-looking information based on management's expectations, estimates and projections. All statements that address expectations or projections about the future, including statements about the Company's strategy for growth, product development, market position, expected expenditures, and the expected synergies following the closing are forward-looking statements. All third party claims referred to in this release are not guaranteed to be accurate. All third party references to market information in this release are not guaranteed to be accurate as the Company did not conduct the original primary research. These statements are not a guarantee of future performance and involve a number of risks, uncertainties and assumptions. Although the Company has attempted to identify important factors that could cause actual results to differ materially, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Leseranfragen:
EnWave Corporation ist ein in Vancouver ansässiges Technologieunternehmen das kommerzielle Applikationen für ihre geschützte Radiant Energy Vacuum (REV™) Trocknungstechnologie anbietet.
" alt="Far Resources to Acquire 100% of Zoro Lithium Property, Snow Lake, Manitoba
Datum: 09.05.2017 - 15:02 Uhr
Sprache: Deutsch
News-ID 541262
Anzahl Zeichen: 5084
contact information:
Town:
Wien
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 228 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"EnWave Signs Technology Evaluation and License Option Agreement with Major Australasian Dairy Processor
"
steht unter der journalistisch-redaktionellen Verantwortung von
EnWave Corporation (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
